The effects of phototherapy on quality of life in allergic rhinitis cases

  • Cemal Cingi
  • Aytekin Yaz
  • Hamdi Cakli
  • Erkan Ozudogru
  • Cem Kecik
  • Cengiz Bal
Rhinology

Abstract

Phototherapy, using a combination of UV-A (25%), UV-B (5%) and visible light (70%), is known to be affective in suppressing the clinical symptoms of allergic rhinitis significantly. It has also been shown that phototherapy locally reduces the number of inflammatory cells and the level of mediators. We aimed to investigate the efficacy of phototherapy in improving the quality of life of patients with allergic rhinitis using Rhinoconjunctivitis Quality of Life Questionnaire, besides checking the total symptom scores of 100 consecutive cases. When the previous and after treatment data were compared, statistically significant differences were found in all quality of life variables (P < 0.001). These results suggest that phototherapy is an effective method to relieve symptoms of allergic rhinitis and has a positive effect on the quality of life of allergic patients. Further studies are needed to plan an ongoing treatment of phototherapy at certain intervals for continuous relief of symptoms and a better and longstanding quality of life.

Keywords

Allergic rhinitis Phototherapy UV light RQLQ Rhinoconjunctivitis Quality of Life Questionnaire Quality of life 

References

  1. 1.
    Koreck A, Csoma Z, Ignacz F, Bodai L, Kadocsa E, Szabo G, Bor Z, Nekam K, Dobozy A, Kemeny L (2005) Intranasal phototherapy for the treatment of allergic rhinitis. Orv Hetil 146(19):965–969PubMedGoogle Scholar
  2. 2.
    Koreck AI, Csoma Z, Bodai L, Ignacz F, Kenderessy AS, Kadocsa E, Szabo G, Bor Z, Erdei A, Szony B, Homey B, Dobozy A, Kemeny L (2005) Rhinophototherapy: a new therapeutic tool for the management of allergic rhinitis. J Allergy Clin Immunol 115(3):541–547CrossRefPubMedGoogle Scholar
  3. 3.
    Csoma Z, Koreck A, Ignacz F, Bor Z, Szabo G, Bodai L, Dobozy A, Kemeny L (2006) PUVA treatment of the nasal cavity improves the clinical symptoms of allergic rhinitis and inhibits the immediate-type hypersensitivity reaction in the skin. J Photochem Photobiol B 83(1):21–26CrossRefPubMedGoogle Scholar
  4. 4.
    Koreck A, Szechenyi A, Morocz M, Cimpean A, Bella Z, Garaczi E, Raica M, Olariu TR, Rasko I, Kemeny L (2007) Effects of intranasal phototherapy on nasal mucosa in patients with allergic rhinitis. J Photochem Photobiol B 89(2–3):163–169. Epub 2007 Oct 5Google Scholar
  5. 5.
    Kemeny L, Koreck A (2007) Ultraviolet light phototherapy for allergic rhinitis. J Photochem Photobiol B; 87(1):58–65. Epub 2007 Jan 19Google Scholar
  6. 6.
    Juniper EF, Guyatt GH (1991) Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 21:77–83CrossRefPubMedGoogle Scholar
  7. 7.
    Juniper EF, Ståhl E, Doty RL, Simons FE, Allen DB, Howarth PH (2005) Clinical outcomes and adverse effect monitoring in allergic rhinitis. J Allergy Clin Immunol 115(3 suppl 1):s390–s413CrossRefPubMedGoogle Scholar
  8. 8.
    Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ (1996) Interpretation of Rhinoconjunctivitis Quality of Life Questionnaire data. J Allergy Clin Immunol 98(4):843–845CrossRefPubMedGoogle Scholar
  9. 9.
    Juniper EF (1997) Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol 99(2):s742–s749CrossRefPubMedGoogle Scholar
  10. 10.
    Juniper EF, Riis B, Juniper BA (2007) Development and validation of an electronic version of the Rhinoconjunctivitis Quality of Life Questionnaire. Allergy 62(9):1091–1093. Epub May 22Google Scholar
  11. 11.
    Juniper EF, Thompson AK, Ferrie PJ, Roberts JN (1999) Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 104(2 Pt 1):364–369CrossRefPubMedGoogle Scholar
  12. 12.
    Juniper EF, Thompson AK, Roberts JN (2002) Can the standard gamble and rating scale be used to measure quality of life in rhinoconjunctivitis? Comparison with the RQLQ and SF-36. Allergy 57(3):201–206CrossRefPubMedGoogle Scholar
  13. 13.
    Sheikh A, Hurwitz B (2003) House dust mite avoidance measures for perennial allergic rhinitis: a systematic review of efficacy. Br J Gen Pract 53(489):318–322PubMedGoogle Scholar
  14. 14.
    Erkara IP, Cingi C, Ayranci U et al (2008) Skin prick test reactivity in allergic rhinitis patients to airborne pollens. Environ Monit Assess, May 7Google Scholar
  15. 15.
    Cingi C, Cakli H, Miman O et al (2007) Correlation of environmental mite levels and the symptoms of allergic rhinitis regarding the efficacy of preventive education. Allergol Immunopathol (Madr) 35(6):243–247CrossRefGoogle Scholar
  16. 16.
    Cingi C, Gurkan Kayabasoglu G, Nacar A (2009) Update on the medical treatment of allergic rhinitis inflammation & allergy—Drug targets, 8, 2Google Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Cemal Cingi
    • 1
  • Aytekin Yaz
    • 1
  • Hamdi Cakli
    • 1
  • Erkan Ozudogru
    • 1
  • Cem Kecik
    • 1
  • Cengiz Bal
    • 2
  1. 1.ENT Department, Medical FacultyEskisehir Osmangazi UniversityEskisehirTurkey
  2. 2.Biostatistics Department, Medical FacultyEskisehir Osmangazi UniversityEskisehirTurkey

Personalised recommendations